Get the Stockscreener App
559.65
0.37%
-2.06
After Hours:
557.89
-1.76
-0.31%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $559.65, with a volume of 2.06M.
It is down -0.37% in the last 24 hours and up +5.83% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
See More
Previous Close:
$561.71
Open:
$562.46
24h Volume:
2.06M
Relative Volume:
1.18
Market Cap:
$214.07B
Revenue:
$42.37B
Net Income/Loss:
$6.14B
P/E Ratio:
35.09
EPS:
15.95
Net Cash Flow:
$7.78B
1W Performance:
+3.20%
1M Performance:
+5.83%
6M Performance:
+0.83%
1Y Performance:
+3.78%
1-Day Range:
$559.11
$565.00
1-Week Range:
$541.67
$565.00
52-Week Range:
$493.30
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research - GlobeNewswire Inc.
LaFleur & Godfrey LLC Buys 2,488 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
UMB Bank n.a. Has $20.91 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Annex Advisory Services LLC Increases Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Key Trends in the Bioinformatics Market with Insights from - openPR
Cohen Klingenstein LLC Lowers Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Lummis Asset Management LP Trims Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Jackson Square Capital LLC Has $3.09 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Smith Salley Wealth Management Grows Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Merit Financial Group LLC Raises Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Householder Group Estate & Retirement Specialist LLC Decreases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Arthur M. Cohen & Associates LLC Reduces Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Trust Co. of Vermont Grows Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific (BUE:TMO) EV-to-EBIT : 40.10 (As of Jan. 18, 2025) - GuruFocus.com
An Intrinsic Calculation For Thermo Fisher Scientific Inc. (NYSE:TMO) Suggests It's 31% Undervalued - Simply Wall St
29,914 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Purchased by Avanza Fonder AB - MarketBeat
Border to Coast Pensions Partnership Ltd Acquires 10,305 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by Foresight Group Ltd Liability Partnership - MarketBeat
Professional Advisory Services Inc. Has $29.12 Million Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
Hennion & Walsh Asset Management Inc. Acquires 2,094 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
$100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
KMG Fiduciary Partners LLC Boosts Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Empirical Asset Management LLC Makes New $34.78 Million Investment in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Carnegie Investment Counsel Acquires 726 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
AI in Nanotechnology Market Top Companies StudyThermo Fisher - openPR
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Argent Capital Management LLC - MarketBeat
Lyndra Therapeutics inks manufacturing services collaboration with Thermo Fisher for long-acting oral therapies - BSA bureau
Lyndra and Thermo Fisher partner for oral therapies - Yahoo Finance
Dixon Mitchell Investment Counsel Inc. Increases Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Gateway Investment Advisers LLC Grows Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Lyndra Therapeutics partners with Thermo Fisher for long-acting therapies - World Pharmaceutical Frontiers
Park Avenue Securities LLC Reduces Stake in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
MicroRNA Market Next Big Thing | Major Giants- Qiagen, Thermo Fisher Scientific, Merck - openPR
Fifth Third Wealth Advisors LLC Grows Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Rockland Trust Co. Purchases 1,721 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
JPM 2025: Thermo Fisher ‘very positive’ on sterile demand as Catalent takes capacity out of market - Pharmaceutical Technology
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies - BioSpace
Lyndra, Thermo Fisher Partner to Bring Long-Acting Oral Therapies to Market - Contract Pharma
Freezing Media Market Is Booming So Rapidly | Thermo Fisher, Merck, Zenoaq, Lonza - openPR
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Purchased by S.E.E.D. Planning Group LLC - MarketBeat
Covea Finance Sells 5,410 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Avity Investment Management Inc. - MarketBeat
2,413 Shares in Thermo Fisher Scientific Inc. (NYSE:TMO) Bought by Pines Wealth Management LLC - MarketBeat
R.H. Investment Group LLC Acquires Shares of 8,904 Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
CCLA Investment Management Has $134.50 Million Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO) - MarketBeat
Pneumonia Testing Market Is Booming Worldwide 2024-2031 | Thermo Fisher Scientific Inc., Abbott Laboratories - EIN News
Pathogen Reduction System Market Size, Trends Analysis 2031 - openPR
JP Morgan 2025: Thermo Fisher Scientific rides momentum to project strong growth in 2025 - Yahoo Finance
Genome Engineering Market Is Booming Worldwide 2024-2031 | Thermo Fisher Scientific Inc., CRISPR Therapeutics - EIN News
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.46%
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):